SciTech Pulse
Health & Bio

Small Trial Finds Time-Restricted Eating May Lower Blood Sugar in Type 1 Diabetes

A University of Illinois Chicago trial found that adults with Type 1 diabetes who ate only within an eight-hour daily window for six months lowered their blood sugar as much as those who cut calories, without added…

Step by step

  1. 1

    32 adults assigned to three groups

  2. 2

    One group eats only noon to 8 p.m.

  3. 3

    Groups followed for six months

  4. 4

    Blood sugar and safety compared

A trial led by University of Illinois Chicago kinesiology and nutrition professor Krista Varady has found that time-restricted eating, a form of intermittent fasting, may help adults with Type 1 diabetes manage their blood sugar. The researchers called it the first study to examine intermittent fasting specifically in people with Type 1 diabetes, a chronic condition in which the body produces little or no insulin and which affects less than 1% of people in the United States.

The trial randomly assigned 32 adults from the Chicago area, all of whom had Type 1 diabetes and were classified as obese, to follow one of three approaches for six months: eating only between noon and 8 p.m. without counting calories, cutting calorie intake by 25%, or making no changes as a control group. The results were published in the journal Diabetes Care.

After six months, the time-restricted eating group had lower blood sugar than the calorie-counting group, with average , a measure of blood sugar over roughly three months, dropping by about 0.5%. The eating schedule did not raise the risk of dangerously high or low blood sugar, or of , a life-threatening complication caused by insufficient insulin.

Varady called the results "extremely promising" but described the trial as a first step, saying anyone with diabetes considering a change to their eating pattern should work closely with an endocrinologist or healthcare provider. She said she now hopes to test the approach in larger, multi-site studies to see whether the results hold more broadly.

Terms explained

The story so far

  1. Peppermint Oil Lowers Blood Pressure in Just 20 Days, Trial Finds
  2. FDA Approves Rasonque, First Drug to Target a Genetic Cause of Pancreatic Cancer
  3. Major Trial Finds Diacerein Does Not Relieve Knee Osteoarthritis Pain
  4. Kentucky Trial Tests Whether Semaglutide Can Reverse Heart Damage From Childhood Obesity
  5. Cytokinetics' Heart Drug Aficamten Hits Goals in Trial for Rare Cardiomyopathy
  6. AstraZeneca's Heart Drug Fails to Add Benefit in Trial for ATTR-CM Patients
  7. Small Trial Finds Time-Restricted Eating May Lower Blood Sugar in Type 1 Diabetes
#intermittent fasting#Type 1 diabetes#clinical trial#blood sugar
Rate this story

Related stories